{
    "organizations": [],
    "uuid": "0191ba2e0ec32f6178cf72ba8454fa421059f694",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-guangzhou-boji-medical-biotechnolo/brief-guangzhou-boji-medical-biotechnological-to-swing-to-loss-in-fy-2017-idUSL4N1PR3OY",
    "ord_in_thread": 0,
    "title": "BRIEF-Guangzhou Boji Medical & Biotechnological to swing to loss in FY 2017",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 1 (Reuters) - Guangzhou Boji Medical & Biotechnological Co Ltd :\n* Sees to swing to net loss at 24 million yuan to 29 million yuan in FY 2017 versus net profit at 2.1 million yuan year ago\n* Says increase in periodic cost and costs of clinical research service business as main reasons for the forecast\nSource text in Chinese: goo.gl/fxEPjs\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-02-01T18:02:00.000+02:00",
    "crawled": "2018-02-02T12:42:23.014+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "guangzhou",
        "boji",
        "medical",
        "biotechnological",
        "co",
        "ltd",
        "see",
        "swing",
        "net",
        "loss",
        "million",
        "yuan",
        "million",
        "yuan",
        "fy",
        "versus",
        "net",
        "profit",
        "million",
        "yuan",
        "year",
        "ago",
        "say",
        "increase",
        "periodic",
        "cost",
        "cost",
        "clinical",
        "research",
        "service",
        "business",
        "main",
        "reason",
        "forecast",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}